Fully automated whole blood cell counters can perform standardized operations in multiple steps after sample loading. However, if the sample is contaminated or the sample volume is insufficient before testing, the test results may be affected.

For laboratories, clinics, and diagnostic partners, establishing a controlled workflow to ensure accurate results for every test is crucial. Ozelle‘s digital diagnostic solutions provide a complete and reliable workflow from sample collection to testing, offering stable technical and workflow support for various testing scenarios.

What factors can affect the test results before analysis?

The pre-analytical phase includes all activities that take place before a blood specimen is measured by the analyzer. In CBC testing, this phase starts with the test request and patient or sample identification, then continues through blood collection, tube selection, labeling, mixing, transport, storage, receipt, and the checks performed before loading the sample.

Common pre-analytical risks include:

• Incorrect patient or specimen identification.
• Incomplete, missing, or mismatched labeling.
• Use of an unsuitable collection tube or anticoagulant.
• Underfilled tubes that may not maintain the intended blood-to-anticoagulant ratio.
• Inadequate mixing after collection.
• Microclots or visible clots in the specimen.
• Delayed delivery or unsuitable transport and storage conditions.
• Leaking, damaged, or insufficient-volume samples.
• Failure to document collection time, receipt time, or sample exceptions.

These issues matter because a fully automated analyzer evaluates the specimen it receives. Automation may standardize the analytical workflow, but it does not make an unsuitable sample representative of the patient.

Start With Identification and Collection Discipline

The first safeguard is positive identification. Before blood is collected, confirm the patient or sample identity according to the laboratory’s approved procedure. Label the tube at the point of collection, using the organization’s traceable identification method, and verify that the label, order, and specimen match before the sample leaves the collection area.

CBC workflows also depend on using the collection tube and sample type specified in the analyzer instructions for use and the laboratory’s validated procedures. Laboratories should define acceptable sample types, fill requirements, collection-to-analysis intervals, transport conditions, and rejection criteria in a written SOP.

A reliable collection routine should include:

• Confirming identity before collection and before labeling.
• Using the approved anticoagulant tube for routine CBC testing.
• Filling the tube within the validated range for the tube and collection method.
• Avoiding unnecessary collection trauma or prolonged handling that could compromise the specimen.
• Recording collection information when required by the laboratory workflow.
• Escalating any uncertainty before the sample is loaded for testing.

For capillary blood workflows, consistency is equally important. Collection technique, sample transfer, anticoagulant contact, and prompt processing should all follow the laboratory’s validated method. A compact analyzer may accept a small sample volume, but the available volume must still be sufficient and appropriate for the selected test procedure.

Mix Correctly and Check for Clots

Inadequate mixing is one of the causes of errors in blood analyzer results. After blood enters the anticoagulant tube, the laboratory’s standard operating procedures (SOPs) should be followed; otherwise, sample collection may be unnecessarily affected.

It is recommended to conduct another acceptance check before collecting samples and preparing for testing.

Proceed to the next step of testing only after confirming that the labeling, testing sequence, and sample identification are consistent; that approved blood collection tubes and sample types have been used; that the sample volume meets the testing method requirements; that the container is intact; that there are no visible clots or suspected microclot-related issues; that the time interval from data acquisition to analysis remains within the validated workflow; and that all anomalies have been documented.

If a specimen is not acceptable, staff should follow the laboratory’s defined review, rejection, or recollection procedure. An analyzer may produce flags, numerical results, histograms, image-related information, or other instrument-specific outputs. These outputs can be valuable for laboratory review, but they should not replace specimen acceptance procedures or defined smear-review and result-review criteria.

Control Transport, Storage, and Timing

Transportation is also a source of testing errors. Different hospital laboratories have different conditions, and therefore, transportation conditions and routes will vary. Developing reasonable sample transportation and handover procedures can reduce the likelihood of errors occurring before testing.

Practical measures include:

• Use defined collection-to-receipt and receipt-to-analysis targets.
• Avoid unnecessary delays between collection and testing.
• Protect specimens from conditions outside the laboratory’s validated transport and storage range.
• Use clear handoff procedures between collection points, couriers, reception staff, and the laboratory.
• Record delays or deviations that may affect sample acceptability.
• Create a clear rule for whether delayed specimens are tested with qualification, held for review, or recollected.

This is especially important for decentralized clinics and point-of-care environments, where collection and analysis may occur in different rooms, departments, or facilities. A fully automated CBC workflow performs best when specimen movement is as standardized as the analyzer workflow itself.

Let Automation Reduce the Right Variables

Automation has an important role in error prevention, but its role should be described accurately. It can reduce variation in many analytical and post-loading steps, such as manual sample preparation, staining, mixing, image acquisition, data transfer, and report generation. It cannot replace correct patient identification, appropriate collection, proper anticoagulant handling, or laboratory-defined sample acceptance criteria.

Ozelle's EHBT-75 7-Diff Auto Hematology Analyzer is designed for automated human hematology workflows using capillary or venous whole blood. Its workflow integrates automated loading, staining, mixing, image-based detection, and AI-assisted cell recognition and classification. The analyzer supports 7-diff hematology and reports morphology-related cell categories including NST, NSG, NSH, ALY, PAg, and RET, alongside routine CBC parameters.

This type of workflow can help laboratories reduce manual handling after a suitable specimen has been accepted. It also supports a more standardized route from sample loading to reporting. However, result interpretation remains dependent on laboratory review practices, relevant patient information, previous results where available, and clinical correlation.

For hospital laboratories with compact space requirements and comprehensive functionality, the EHBT-50 Mini Lab Multifunction Analyzer combines seven-part differential hematology analysis with immunoassays and dry chemistry assays. It supports single, dual, or triple assay configurations within a single batch, and is compatible with venous whole blood, capillary blood, serum, and plasma. Its highly integrated disposable consumables are designed to support maintenance-free workflows, helping to reduce the risk of cross-contamination during instrument operation.

Choose Workflow Fit, Not Automation Alone

The best fully automated CBC machine is not necessarily the system with the most features. It is the system that fits the laboratory’s validated sample pathway, expected workload, staffing model, reporting requirements, and local support capabilities. A clinic or specialist unit performing routine CBC testing may prioritize a compact analyzer with a controlled automated sample-processing workflow. A department that requires hematology alongside selected immunoassay and dry-chemistry tests may benefit from an integrated multi-functional analyzer. For laboratories managing larger or more variable CBC workloads, a workflow designed around batch loading, barcode traceability, automated sample handling, STAT priority processing, and scalable capacity can help reduce avoidable handoffs and support more consistent routine operations.

In this type of setting, O-Cyte 1 provides an example of a scalable automated hematology workflow. It supports 25-position batch loading, random tube placement, automatic barcode identification, automatic mixing, closed-tube piercing, and STAT priority mode. The analyzer supports up to 60 tests per hour as a standalone unit and up to 360 tests per hour through cascaded expansion. Its closed-fluidics architecture, modular design, and internal morphology liquid QC support are intended to help laboratories organize routine hematology testing and manage changing workload demands, while laboratory review and defined result-release procedures remain essential.

The key question is not whether automation can eliminate all pre-analytical errors. It cannot. The better question is whether the laboratory has designed a workflow in which correct collection, traceable identification, controlled specimen handling, appropriate automation, QC, and result review work together.

Reliable Complete Blood Count Results Begin with Standardized Preliminary Preparation

Automated complete blood count (CBC) analyzers can provide information to support disease assessment, but reliable test results require careful control at every stage. To reduce pre-analysis errors, each step must be accurate.

Establishing a complete workflow from sample collection to sample testing and finally obtaining test results is the responsibility of modern hematology hospital laboratories. It is not only about ensuring test results but also about being accountable to patients.